Skip to content
10-K

Annual Report

IRIS BIOTECHNOLOGIES INC

0001554795-16-000602

← back to feed
Filed
Mar 30, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 30, 2016 19.68M sh
Capex FY 2015 · Dec 31, 2015 $26.81K
Capex FY 2015 · Dec 31, 2014 $7.45K
Operating Cash Flow FY 2015 · Dec 31, 2015 −$451.28K
Operating Cash Flow FY 2015 · Dec 31, 2014 −$640.4K
Cash And Equivalents FY 2015 · Dec 31, 2015 $19.84K
Cash And Equivalents FY 2015 · Dec 31, 2014 $322.93K
Cash And Equivalents FY 2015 · Dec 31, 2013 $18.99K
Stockholders Equity FY 2015 · Dec 31, 2015 −$441.5K
Stockholders Equity FY 2015 · Dec 31, 2014 $63.6K
Stockholders Equity FY 2015 · Dec 31, 2013 −$184.05K
Current Liabilities FY 2015 · Dec 31, 2015 $468.58K
Current Liabilities FY 2015 · Dec 31, 2014 $242.21K
Total Liabilities FY 2015 · Dec 31, 2015 $494.58K
Total Liabilities FY 2015 · Dec 31, 2014 $268.21K
Current Assets FY 2015 · Dec 31, 2015 $23.46K
Current Assets FY 2015 · Dec 31, 2014 $322.93K
Total Assets FY 2015 · Dec 31, 2015 $53.08K
Total Assets FY 2015 · Dec 31, 2014 $331.82K
Sga Expense FY 2015 · Dec 31, 2015 $859.61K
Sga Expense FY 2015 · Dec 31, 2014 $987.88K
Rd Expense FY 2015 · Dec 31, 2015 $192.41K
Rd Expense FY 2015 · Dec 31, 2014 $199.66K
Net Income FY 2015 · Dec 31, 2015 −$1.17M
Net Income FY 2015 · Dec 31, 2014 −$1.19M
Operating Income FY 2015 · Dec 31, 2015 −$1.06M
Operating Income FY 2015 · Dec 31, 2014 −$1.19M